doi:10.19982/j.issn.1000-6621.20230031

Abstract

CLC Number:

R52
R151

References 23

[1]	石国帅, 成君, 夏愔愔, 等. 336例初治菌阳肺结核患者膳食状况调查分析. 中国防痨杂志, 2017, 39(5): 488-494. doi:10.3969/j.issn.1000-6621.2017.05.015. doi: 10.3969/j.issn.1000-6621.2017.05.015
[2]	Ji F, Yang Y, Xu L, et al. Poor diet quality evaluated with the China Healthy Diet Index in Chinese tuberculosis patients. J Hum Nutr Diet, 2022, 35(6): 1192-1201. doi:10.1111/jhn.12985. doi: 10.1111/jhn.12985 URL
[3]	唐石铜. 高胆固醇饮食辅助治疗肺结核60例临床分析. 中国社区医师:医学专业, 2006(18): 44.
[4]	World Health Organization. Global tuberculosis report 2017. Geneva: World Health Organization, 2017.
[5]	Sinha P, Lönnroth K, Bhargava A, et al. Food for thought: addressing undernutrition to end tuberculosis. Lancet Infect Dis, 2021, 21(10): e318-e325. doi: 10.1016/S1473-3099(20)30792-1 pmid: 33770535
[6]	Grobler L, Nagpal S, Sudarsanam T, et al. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev, 2016, 2016(6): CD006086. doi:10.1002/14651858.CD006086.pub4. doi: 10.1002/14651858.CD006086.pub4
[7]	Kandi S, K TK, Kandi SR, et al. Study of treatment outcomes of multidrug-resistant tuberculosis under programmatic conditions and factors influencing the outcomes in Hyderabad District. Indian J Tuberc, 2021, 68(3): 379-383. doi:10.1016/j.ijtb.2020.12.008. doi: 10.1016/j.ijtb.2020.12.008 pmid: 34099204
[8]	Schaaf HS, Cilliers K, Willemse M, et al. Nutritional status and its response to treatment of children, with and without HIV infection, hospitalized for the management of tuberculosis. Paediatr Int Child Health, 2012, 32(2): 74-81. doi:10.1179/2046905512Y.0000000008. doi: 10.1179/2046905512Y.0000000008 URL
[9]	Choi R, Jeong BH, Koh WJ, et al. Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations. Ann Lab Med, 2017, 37(2): 97-107. doi:10.3343/alm.2017.37.2.97. doi: 10.3343/alm.2017.37.2.97 pmid: 28028995
[10]	Bacelo AC, do Brasil PE, Cople-Rodrigues CD, et al. Dietary counseling adherence during tuberculosis treatment: A longitudinal study. Clin Nutr ESPEN, 2017, 17: 44-53. doi:10.1016/j.clnesp.2016.11.001. doi: S2405-4577(16)30333-3 pmid: 28361747
[11]	Selvaraj P, Harishankar M, Afsal K. Vitamin D: Immuno-modulation and tuberculosis treatment. Can J Physiol Pharmacol, 2015, 93(5): 377-384. doi:10.1139/cjpp-2014-0386. doi: 10.1139/cjpp-2014-0386 URL
[12]	Cubillos-Angulo JM, Nogueira BMF, Arriaga MB, et al. Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs. Front Med(Lausanne), 2022, 9: 970408. doi:10.3389/fmed.2022.970408. doi: 10.3389/fmed.2022.970408
[13]	Huey SL, Yu EA, Finkelstein JL, et al. Nutrition, Inflammation, and the Gut Microbiota among Outpatients with Active Tuberculosis Disease in India. Am J Trop Med Hyg, 2021, 105(6): 1645-1656. doi:10.4269/ajtmh.21-0310. doi: 10.4269/ajtmh.21-0310 URL
[14]	Castillo-Martínez L, Castro-Eguiluz D, Copca-Mendoza ET, et al. Nutritional Assessment Tools for the Identification of Malnutrition and Nutritional Risk Associated with Cancer Treatment. Rev Invest Clin, 2018, 70(3): 121-125. doi:10.24875/RIC.18002524. doi: 10.24875/RIC.18002524 pmid: 29943772
[15]	Rabito EI, Marcadenti A, da Silva Fink J, et al. Nutritional Risk Screening 2002, Short Nutritional Assessment Questionnaire, Malnutrition Screening Tool, and Malnutrition Universal Screening Tool Are Good Predictors of Nutrition Risk in an Emergency Service. Nutr Clin Pract, 2017, 32(4): 526-532. doi:10.1177/0884533617692527. doi: 10.1177/0884533617692527 pmid: 28199797
[16]	Chávez-Tostado M, Cervantes-Guevara G, López-Alvarado SE, et al. Comparison of nutritional screening tools to assess nutritional risk and predict clinical outcomes in Mexican patients with digestive diseases. BMC Gastroenterol, 2020, 20(1):79. doi:10.1186/s12876-020-01214-1. doi: 10.1186/s12876-020-01214-1 pmid: 32216787
[17]	Castro JDS, Santos CAD, Rosa COB, et al. STRONGkids nutrition screening tool in pediatrics: An analysis of cutoff points in Brazil. Nutr Clin Pract, 2022, 37(5): 1225-1232. doi:10.1002/ncp.10807. doi: 10.1002/ncp.10807 URL
[18]	Santos CAD, Rosa COB, Franceschini SDCC, et al. Nutrition Risk Assessed by STRONGkids Predicts Longer Hospital Stay in a Pediatric Cohort: A Survival Analysis. Nutr Clin Pract, 2021, 36(1): 233-240. doi:10.1002/ncp.10589. doi: 10.1002/ncp.10589 pmid: 33175423
[19]	Santos CAD, Rosa COB, Franceschini SDCC, et al. StrongKids for pediatric nutritional risk screening in Brazil: a validation study. Eur J Clin Nutr, 2020, 74(9):1299-1305. doi:10.1038/s41430-020-0644-1. doi: 10.1038/s41430-020-0644-1 pmid: 32371986
[20]	Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition-A consensus report from the global clinical nutrition community. Clin Nutr, 2019, 38(1): 1-9. doi:10.1016/j.clnu.2018.08.002. doi: S0261-5614(18)31344-X pmid: 30181091
[21]	Zhang X, Tang M, Zhang Q, et al. The GLIM criteria as an effective tool for nutrition assessment and survival prediction in older adult cancer patients. Clin Nutr, 2021, 40(3): 1224-1232. doi:10.1016/j.clnu.2020.08.004. doi: 10.1016/j.clnu.2020.08.004 pmid: 32826109
[22]	Fiorindi C, Luceri C, Dragoni G, et al. GLIM Criteria for Malnutrition in Surgical IBD Patients: A Pilot Study. Nutrients, 2020, 12(8): 2222. doi:10.3390/nu12082222. doi: 10.3390/nu12082222 URL
[23]	Ji T, Li Y, Liu P, et al. Validation of GLIM criteria on malnutrition in older Chinese inpatients. Front Nutr, 2022, 9:969666. doi:10.3389/fnut.2022.969666. doi: 10.3389/fnut.2022.969666 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 23

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397.
[2]	Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407.
[3]	Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
[4]	Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424.
[5]	Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431.
[6]	An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438.
[7]	Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443.
[8]	Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453.
[9]	Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459.
[10]	Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470.
[11]	Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476.
[12]	Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481.
[13]	Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497.
[14]	Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504.
[15]	Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512.